Ultragenyx Pharmaceutical Inc. Profile Avatar - Palmy Investing

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internat…
Biotechnology
US, Novato [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

A quick analysis that compared Ultragenyx Pharmaceutical Inc. (RARE) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.

Company Price Change Volume, Avg. Market Cap. Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding
Biotechnology Average - - - - - - 13,382.43 894.68 137.45 358.64 14.73 0.00 24.3930 -0.87 -0.9106 -21.3735 -0.08 -0.07 7.1836 - -
Maximum - - - - - - 444,129.00 65,349.00 25,407.00 99,050.00 5,305.00 0.02 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -6,783.00 -56,335.00 -2,077.00 0.00 -164.8536 -57.22 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Apellis Pharmaceuticals, Inc. APLS 27.75 0.26 0.95% 1,488 vs. 2,868 3,451.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 124.00
United Therapeutics Corporation UTHR 367.36 3.03 0.83% 201 vs. 363 16,400.00 677.00 306.00 338.00 6,333.00 6.5200 8.7477 0.0000 0.8924 0.4524 0.0574 0.0472 3.5035 44.00
Incyte Corporation INCY 70.39 -0.66 -0.93% 2,109 vs. 2,066 13,560.00 880.00 169.00 209.00 329.00 0.7600 18.7480 0.0000 0.9308 0.1925 0.0314 0.0238 3.2913 192.00
Alnylam Pharmaceuticals, Inc. ALNY 246.80 -1.99 -0.80% 676 vs. 859 31,832.00 494.00 -65.00 -94.00 -7,075.00 -0.5200 -73.3326 0.0000 0.8665 -0.1334 0.3007 -0.0172 2.8593 128.00
Ultragenyx Pharmaceutical Inc. RARE 46.02 -0.38 -0.82% 509 vs. 723 4,249.00 108.00 -170.00 -203.00 -3,558.00 -2.0300 -5.7986 0.0000 0.7576 -1.5683 -1.2169 -0.1306 2.1127 92.00
Revolution Medicines, Inc. RVMD 56.78 -0.29 -0.51% 864 vs. 1,174 9,551.00 0.00 -116.00 -163.00 -1,253.00 -0.7000 -11.2467 0.0000 0.0000 0.0000 -0.0672 -0.0608 18.1763 168.00
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for RARE and its peers to uncover potential buy and sell opportunities.
End of RARE's Analysis
CIK: 1515673 CUSIP: 90400D108 ISIN: US90400D1081 LEI: - UEI: -
Secondary Listings
RARE has no secondary listings inside our databases.